EFSA Raises Neotame Safety Limit by 5 Times Confirms No Health Risks
On July 4, 2025, the European Food Safety Authority (EFSA) announced the results of its re-evaluation of neotame (E 961), a widely used artificial sweetener. The EFSA's Food Additives and Flavourings Panel (FAF) has increased the acceptable daily intake (ADI) from 2 mg/kg body weight (bw) per day to 10 mg/kg bw per day, based on updated toxicological data.
Neotame is a chemically synthesized compound with the main impurity NC-00751, which is also its primary metabolite. EFSA reviewed toxicological studies, including long-term carcinogenicity tests on rats, which showed no adverse effects at doses as high as 1,000 mg/kg bw per day. The panel confirmed that neotame is rapidly metabolized and excreted, with no evidence of genotoxicity or aneugenic effects at permitted levels.
Even at the revised ADI of 10 mg/kg bw per day, the exposure to methanol and its metabolite formaldehyde does not raise health concerns. Dietary exposure estimates across all population groups remain well within this limit, ensuring safety at current use levels.
EFSA recommended that the European Commission update the EU specifications for neotame (E 961) to reflect the latest findings. The re-evaluation confirms that neotame poses no safety concerns at authorized levels, providing reassurance for its continued use in the food industry.
2026-09-09
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Global Countries Impose Tariffs on Chinese Chemical Products
-
Rare Earth and Power: Strategic Probing Beneath the New U.S.–China Trade Framework
-
U.S. Chemical Tariff Deadline Nears as the Industry Faces Cost Repricing and Supply-Chain Adjustment
-
EU Finalizes Anti-Dumping Duties on Chinese Adipic Acid as Chemical Trade Enters a Rule-Intensive Phase
-
EU Biocidal Data Protection Extension Raises the Stakes for Chemical Market Entry
-
China's National Narcotics Control Commission Issues Important Notice: Beware of These 8 Chemicals Being Diverted for Drug Production
-
API Supplier Audits Move to the Center of Pharma Supply Resilience
-
Supplement Recall Puts Nutrition Ingredient Safety Back Under Pressure
-
Chemours Sells Its Former Titanium Dioxide Site in Taiwan: Turning a “White Powder” Factory into “Wind Power Real Estate” for $360 Million—Buying Not Cash, But Breathing Room
-
The “Counter-Wind Ledger” of CHF 11.2 Billion: Sika Barely Grew in 2025—Yet Kept Taking Market Share
Recommend Reading
-
Guangxi Huayi Starts 300,000-Tonne VAM Unit: EVA Chain Keeps Expanding
-
GM Crop Area Hits 216 Million Hectares: Trait-Driven Farming Expands
-
Sumitomo Chemical Launches Pilot Plant for Ethanol-to-Propylene Process
-
Snack Tests Put Red 40, Titanium Dioxide and BHT Back Under Pressure
-
A $25 Billion Bill Hits Global Companies as Chemical Costs Are Repriced
-
October Sodium Metabisulfite Prices Decline
-
Weak demand for downstream formic acid in China leads to fluctuating prices
-
MTBE Market Trend Fluctuates Higher in China
-
Downstream Demand Weak, Cyclohexane Market Ranges Narrowly Lower in October
-
Weak Supply and Demand Continue to Weigh Down Melamine Market